{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T14:19:36Z","timestamp":1775312376575,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41431-018-0111-9","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T11:44:36Z","timestamp":1519645476000},"page":"848-857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The association between cancer family history and ovarian cancer risk in BRCA1\/2 mutation carriers: can it be explained by the mutation position?"],"prefix":"10.1038","volume":"26","author":[{"name":"HEBON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemieke","family":"van der Hout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Oosterwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet R.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Devilee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaartje","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Meijers-Heijboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob B.","family":"van der Luijt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieke","family":"Kriege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3805-877X","authenticated-orcid":false,"given":"Arjen R.","family":"Mensenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti A.","family":"Rookus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kees E.","family":"van Roozendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian J. E.","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3104-4471","authenticated-orcid":false,"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"111_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u201386.","journal-title":"Int J Cancer"},{"key":"111_CR2","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK, et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA. 2011;108:18032\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"111_CR3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329\u201333.","journal-title":"J Clin Oncol"},{"key":"111_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812\u201322.","journal-title":"J Natl Cancer Inst"},{"key":"111_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","volume":"51","author":"RM Brohet","year":"2014","unstructured":"Brohet RM, Velthuizen ME, Hogervorst FB, et al. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet. 2014;51:98\u2013107.","journal-title":"J Med Genet"},{"key":"111_CR6","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1200\/JCO.2014.59.0463","volume":"33","author":"JR Vos","year":"2015","unstructured":"Vos JR, Hsu L, Brohet RM, et al. Bias correction methods explain much of the variation seen in breast cancer risks of BRCA1\/2 mutation carriers. J Clin Oncol. 2015;33:2553\u201362.","journal-title":"J Clin Oncol"},{"key":"111_CR7","doi-asserted-by":"publisher","first-page":"T69","DOI":"10.1530\/ERC-16-0277","volume":"23","author":"RL Milne","year":"2016","unstructured":"Milne RL, Antoniou AC. Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers. Endocr Relat Cancer. 2016;23:T69\u201384.","journal-title":"Endocr Relat Cancer"},{"key":"111_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/00016340902807207","volume":"88","author":"M Soegaard","year":"2009","unstructured":"Soegaard M, Frederiksen K, Jensen A, et al. Risk of ovarian cancer in women with first-degree relatives with cancer. Acta Obstet Gynecol Scand. 2009;88:449\u201356.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"111_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/ijc.11151","volume":"105","author":"K Hemminki","year":"2003","unstructured":"Hemminki K, Granstrom C. Familial invasive and borderline ovarian tumors by proband status, age and histology. Int J Cancer. 2003;105:701\u20135.","journal-title":"Int J Cancer"},{"key":"111_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1158\/1055-9965.EPI-05-0687","volume":"15","author":"JS Lee","year":"2006","unstructured":"Lee JS, John EM, McGuire V, et al. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations. Cancer Epidemiol Biomark Prev. 2006;15:359\u201363.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"111_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1471-0528.1998.tb10148.x","volume":"105","author":"JF Stratton","year":"1998","unstructured":"Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998;105:493\u20139.","journal-title":"Br J Obstet Gynaecol"},{"key":"111_CR12","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/jnci\/djq443","volume":"102","author":"K Metcalfe","year":"2010","unstructured":"Metcalfe K, Lubinski J, Lynch HT, et al. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. J Natl Cancer Inst. 2010;102:1874\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"111_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ng1295-428","volume":"11","author":"SA Gayther","year":"1995","unstructured":"Gayther SA, Warren W, Mazoyer S, et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet. 1995;11:428\u201333.","journal-title":"Nat Genet"},{"key":"111_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ng0197-103","volume":"15","author":"SA Gayther","year":"1997","unstructured":"Gayther SA, Mangion J, Russell P, et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet. 1997;15:103\u20135.","journal-title":"Nat Genet"},{"key":"111_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1086\/318181","volume":"68","author":"D Thompson","year":"2001","unstructured":"Thompson D, Easton D, Breast Cancer Linkage Consortium. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet. 2001;68:410\u20139.","journal-title":"Am J Hum Genet"},{"key":"111_CR16","first-page":"329","volume":"11","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton D, Breast Cancer Linkage Consortium. Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomark Prev. 2002;11:329\u201336.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"111_CR17","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR, Mitra N, Wan F, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313:1347\u201361.","journal-title":"JAMA"},{"key":"111_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.maturitas.2015.07.001","volume":"82","author":"N Teixeira","year":"2015","unstructured":"Teixeira N, Mourits MJ, Vos JR, et al. Ovarian cancer in BRCA1\/2 mutation carriers: the impact of mutation position and family history on the cancer risk. Maturitas. 2015;82:197\u2013202.","journal-title":"Maturitas"},{"key":"111_CR19","unstructured":"National Comprehensive Cancer Network (NCCN): NCCN clinical practice in oncology (NCCN guidelines). Genetic\/familial high-risk assessment: breast and ovarian. Version 2.2017. 2016; 2017."},{"key":"111_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","volume":"18","author":"SS Faubion","year":"2015","unstructured":"Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18:483\u201391.","journal-title":"Climacteric"},{"key":"111_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10549-009-0476-0","volume":"120","author":"A Pijpe","year":"2010","unstructured":"Pijpe A, Manders P, Brohet RM, et al. Physical activity and the risk of breast cancer in BRCA1\/2 mutation carriers. Breast Cancer Res Treat. 2010;120:235\u201344.","journal-title":"Breast Cancer Res Treat"},{"key":"111_CR22","unstructured":"Casparie M1, Tiebosch AT, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29(1):19-24"},{"key":"111_CR23","unstructured":"RStudio: Integrated development environment for R (Version 0.98.1091) [Computer software]. Boston, MA. Retrieved December 2014."},{"key":"111_CR24","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402\u201316.","journal-title":"JAMA"},{"key":"111_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/aje\/kwu258","volume":"181","author":"P Tehranifar","year":"2015","unstructured":"Tehranifar P, Wu HC, Shriver T, Cloud AJ, Terry MB. Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reporters. Am J Epidemiol. 2015;181:204\u201312.","journal-title":"Am J Epidemiol"},{"key":"111_CR26","doi-asserted-by":"publisher","first-page":"dju091","DOI":"10.1093\/jnci\/dju091","volume":"106","author":"TM Friebel","year":"2014","unstructured":"Friebel TM, Domchek SM, Rebbeck TR. Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju091.","journal-title":"J Natl Cancer Inst"},{"key":"111_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ng.3185","volume":"47","author":"KB Kuchenbaecker","year":"2015","unstructured":"Kuchenbaecker KB, Ramus SJ, Tyrer J, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015;47:164\u201371.","journal-title":"Nat Genet"},{"key":"111_CR28","doi-asserted-by":"publisher","first-page":"e1003212","DOI":"10.1371\/journal.pgen.1003212","volume":"9","author":"FJ Couch","year":"2013","unstructured":"Couch FJ, Wang X, McGuffog L, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 2013;9:e1003212.","journal-title":"PLoS Genet"},{"key":"111_CR29","doi-asserted-by":"publisher","unstructured":"Kuchenbaecker KB, McGuffog L, Barrowdale D et al. Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2017; 109: \n                    https:\/\/doi.org\/10.1093\/jnci\/djw302\n                    \n                  .","DOI":"10.1093\/jnci\/djw302"},{"key":"111_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009;101:80\u201387.","journal-title":"J Natl Cancer Inst"},{"key":"111_CR31","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","volume":"91","author":"AC Antoniou","year":"2004","unstructured":"Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer. 2004;91:1580\u201390.","journal-title":"Br J Cancer"},{"key":"111_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet. 1998;62:145\u201358.","journal-title":"Am J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0111-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0111-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0111-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:42:06Z","timestamp":1684618926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-018-0111-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1038\/s41431-018-0111-9","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"24 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}